An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women

Vaccine

Volumn 30, Issue 31, 2012, Pages 4585-4587

  Jacobsen, Steven J ^a   Sy, Lina S ^a   Ackerson, Bradley K ^a   Chao, Chun R ^a   Slezak, Jeff M ^a   Cheetham, T Craig ^a   Takhar, Harpreet S ^a   Velicer, Christine M ^b   Hansen, John ^a   Klein, Nicola P ^a  

^a KAISER PERMANENTE   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Adverse event; Bias; Methodology; Vaccine safety

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; DRUG SAFETY; FEMALE; GRAVES DISEASE; HUMAN; LICENCE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD; SIDE EFFECT; SUBCLINICAL HYPERTHYROIDISM; THYROTROPIN BLOOD LEVEL; VACCINATION;

ADOLESCENT; ADULT; AUTOIMMUNE DISEASES; CHILD; DRUG EVALUATION; DRUG TOXICITY; FEMALE; GRAVES DISEASE; HUMANS; PAPILLOMAVIRUS VACCINES; PRODUCT SURVEILLANCE, POSTMARKETING; YOUNG ADULT;

EID: 84861982586     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.103     Document Type: Article

References (11)

1. Moore K.M., Duddy A., Lee G.M., Velentgas P., Burwen D.R., Platt R., et al. Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection. Journal of Clinical Epidemiology 2010, 63:407-411.
2. Shui I.M., Shi P., Dutta-Linn M.M., Weintraub E.S., Hambidge S.J., Nordin J.D., et al. Predictive value of seizure ICD-9 codes for vaccine safety research. Vaccine 2009, 27:5307-5312.
3. Jacobsen S.J., Ackerson B.K., Sy L.S., Tran T.N., Jones T.L., Yao J.F., et al. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting. Vaccine 2009, 27:4656-4661.
4. Black S., Shinefield H., Ray P., Lewis E., Hansen J., Schwalbe J., et al. Postmarketing evaluation of the safety and effectiveness of varicella vaccine. Pediatric Infectious Disease Journal 1999, 18:1041-1046.
5. Klein N.P., Fireman B., Yih W.K., Lewis E., Kulldorff M., Ray P., et al. Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures. Pediatrics 2010, 126:e1-e8.
6. Greene S.K., Kulldorff M., Lewis E.M., Li R., Yin R., Weintraub E.S., et al. Near real-time surveillance for influenza vaccine safety: proof-of-concept in the Vaccine Safety Datalink Project. American Journal of Epidemiology 2010, 171:177-188.
7. Jackson L.A., Yu O., Belongia E.A., Hambidge S.J., Nelson J., Baxter R., et al. Frequency of medically attended adverse events following tetanus and diphtheria toxoid vaccine in adolescents and young adults: a Vaccine Safety Datalink study. BMC Infectious Diseases 2009, 9:165.
8. France E.K., Glanz J.M., Xu S., Davis R.L., Black S.B., Shinefield H.R., et al. Safety of the trivalent inactivated influenza vaccine among children: a population-based study. Archives of Pediatrics and Adolescent Medicine 2004, 158:1031-1036.
9. Rand C.M., Shone L.P., Albertin C., Auinger P., Klein J.D., Szilagyi P.G. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Archives of Pediatrics and Adolescent Medicine 2007, 161:252-259.
10. Chao C., Klein N.P., Velicer C.M., Sy L.S., Slezak J.M., Takhar H., et al. Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. Journal of Internal Medicine 2012, 271:193-203.
11. Jackson L.A., Yu O., Nelson J.C., Dominguez C., Peterson D., Baxter R., et al. Injection site and risk of medically attended local reactions to acellular pertussis vaccine. Pediatrics 2011, 127:e581-e587.